Neuros Medical
Neuros Medical, Inc.: A neuromodulation company developing therapies to eliminate chronic pain.
- 41
- Public company
- Aliso Viejo, CA, USUnited States
Neuros Medical, Inc.: A neuromodulation company developing therapies to eliminate chronic pain.
neurosmedical.comCrawled Oct 15, 2026
Neuros Medical, Inc. announced acceptance for publication of the QUEST Study’s 3-month results, which report immediate and lasting pain reduction, decreased opioid use, and improved quality of life.
Neuros Medical, Inc. completed the QUEST Pivotal Trial’s 90-day primary endpoints. Outcomes will remain blinded through the 12-month follow-up period, per protocol.
The Altius System represents a significant advancement in the treatment of chronic intractable post-amputation pain
Neuros Medical, Inc. makes on-demand bioelectric nerve block therapy for patients with intractable post-amputation pain. David Veino was appointed president and CEO and will join the board; Thomas Wilder is joining the board as an independent director.
Giving patients the ability to gain power over pain
Altius is an FDA-approved device for controlling chronic post-amputation pain and providing relief on demand.
Neuros Medical implants its Altius Direct Electrical Nerve Stimulation System in the first US commercial procedure for managing post-amputation pain. The Altius System targets nerve stimulation to address chronic pain in amputees. This marks the system’s first commercial deployment in the United States.
Jul 2025Medical Device DevelopmentsNews article
Neuros Medical secures a $56 million Series D funding round to advance its nerve stimulation technology. The oversubscribed financing supports further development of its medical devices targeting nerve modulation. The company focuses on therapeutic applications for neurological conditions.
Jul 2025MassDeviceNews article
EQT Life Sciences leads a **$56 million Series D** round to fund **Neuros Medical’s** commercialization of an **FDA-approved treatment** for post-amputation pain. The investment supports the company’s mission to develop therapies that relieve chronic pain and improve quality of life for amputees. Neuros Medical now advances its clinical and operational scale-up with backing from EQT and syndicate partners.
Jul 2025eqtgroup.comNews article
Neuros Medical raises **$56 million in Series D funding** to expand commercialization of the **Altius Direct Electrical Nerve Stimulation System**, an FDA-approved non-opioid therapy for chronic post-amputation pain. The device targets nerve stimulation as an alternative to opioid-based treatments, addressing a critical unmet need in pain management for amputees. The funding will accelerate market adoption and production scaling.
Jul 2025PR NewswireNews article